Similarly, 35 out of 41 (85.37%) malignant ovarian tumors were Fn14 positive, compared to 1 out of 30 (3.33%) in normal ovarian tissues plus borderline/benign tumors (Figure 1A) (p<0.05). This evidence concerns the gene TNFRSF12A and ovarian cancer.